These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Macular corneal dystrophy: reduction in both corneal thickness and collagen interfibrillar spacing. Quantock AJ, Meek KM, Ridgway AE, Bron AJ, Thonar EJ. Curr Eye Res; 1990 Apr; 9(4):393-8. PubMed ID: 2340750 [Abstract] [Full Text] [Related]
9. Synchrotron x-ray diffraction studies of keratoconus corneal stroma. Fullwood NJ, Tuft SJ, Malik NS, Meek KM, Ridgway AE, Harrison RJ. Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1734-41. PubMed ID: 1559773 [Abstract] [Full Text] [Related]
10. Immunohistochemical classification of primary and recurrent macular corneal dystrophy in Germany: subclassification of immunophenotype I A using a novel keratan sulfate antibody. Cursiefen C, Hofmann-Rummelt C, Schlötzer-Schrehardt U, Fischer DC, Haubeck HD, Küchle M, Naumann GO. Exp Eye Res; 2001 Nov; 73(5):593-600. PubMed ID: 11747360 [Abstract] [Full Text] [Related]
11. Abnormalities of proteoglycans and glycoproteins synthesized by corneal organ cultures derived from patients with macular corneal dystrophy. Klintworth GK, Smith CF. Lab Invest; 1983 May; 48(5):603-12. PubMed ID: 6601743 [Abstract] [Full Text] [Related]
12. Research into the pathogenesis of macular corneal dystrophy. Klintworth GK. Trans Ophthalmol Soc U K (1962); 1980 Apr; 100(Pt 1):186-94. PubMed ID: 6973846 [Abstract] [Full Text] [Related]
13. Alterations in stromal glycoconjugates in macular corneal dystrophy. Panjwani N, Rodrigues MM, Alroy J, Albert D, Baum J. Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1211-6. PubMed ID: 3488295 [Abstract] [Full Text] [Related]
14. [Immunohistochemical characterization of collagen IV in control corneas and in corneas obtained from patients suffering from posterior polymorphous corneal dystrophy]. Merjavá S, Lisková P, Jirsová K. Cesk Slov Oftalmol; 2008 May; 64(3):115-9. PubMed ID: 18630163 [Abstract] [Full Text] [Related]
15. [Glycosaminoglycans associate with corneal transparency]. Li Y, Yi Y, Feng G, Zheng H, Lin J. Yan Ke Xue Bao; 1991 Jun; 7(2):58-62. PubMed ID: 1844058 [Abstract] [Full Text] [Related]
16. Macular corneal dystrophy: the macromolecular structure of the stroma observed using electron microscopy and synchrotron X-ray diffraction. Meek KM, Quantock AJ, Elliott GF, Ridgway AE, Tullo AB, Bron AJ, Thonar EJ. Exp Eye Res; 1989 Dec; 49(6):941-58. PubMed ID: 2515072 [Abstract] [Full Text] [Related]
17. Altered fine structures of corneal and skeletal keratan sulfate and chondroitin/dermatan sulfate in macular corneal dystrophy. Plaas AH, West LA, Thonar EJ, Karcioglu ZA, Smith CJ, Klintworth GK, Hascall VC. J Biol Chem; 2001 Oct 26; 276(43):39788-96. PubMed ID: 11514545 [Abstract] [Full Text] [Related]
18. Synchrotron x-ray diffraction studies of the cornea, with implications for stromal hydration. Meek KM, Fullwood NJ, Cooke PH, Elliott GF, Maurice DM, Quantock AJ, Wall RS, Worthington CR. Biophys J; 1991 Aug 26; 60(2):467-74. PubMed ID: 1912282 [Abstract] [Full Text] [Related]
19. An ultrastructural, time-resolved study of freezing in the corneal stroma. Fullwood NJ, Meek KM. J Mol Biol; 1994 Feb 25; 236(3):749-58. PubMed ID: 8114092 [Abstract] [Full Text] [Related]
20. Abnormal product of corneal explants from patients with macular corneal dystrophy. Klintworth GK, Smith CF. Am J Pathol; 1980 Oct 25; 101(1):143-58. PubMed ID: 6969547 [Abstract] [Full Text] [Related] Page: [Next] [New Search]